Business Context and Reporting Period
Company: The Baldwin Insurance Group, Inc. (BWIN)
Filing Type: Form 8-K (Current Report)
Date of Report: December 2, 2025
Event: Entry into a Material Definitive Agreement to acquire the business of Cobbs Allen Capital Holdings, LLC ("Seller").
Key Financial Metrics and Transaction Structure
This filing details a proposed acquisition rather than reporting historical financial performance. The aggregate consideration for the transaction is structured as follows:
- Closing Consideration (Base):
- Cash: $438.0 million (subject to customary purchase price adjustments).
- Equity: 23,200,000 shares of Class A Common Stock (issued only to accredited investor owners).
- Contingent Consideration (Earnout): Up to $250.0 million in cash, payable based on post-closing net commission and fee thresholds.
- Deferred Consideration: $70.0 million in cash, payable on the fourth anniversary of the Closing.
- Lock-up Provisions: 17,400,000 shares of the Equity Consideration are subject to transfer restrictions, released pro rata annually over four years.
Other Financial Notes: The filing does not provide current revenue, profit, cash flow, or debt metrics for the Company or the Seller. The transaction is not subject to a financing condition.
Material Changes and Transaction Details
The primary material change is the agreement to acquire the full business operations of the Seller through a series of mergers and equity purchases:
- Structure: Merger Sub I will merge into CAH Holdings, Inc., which will then merge into Merger Sub II. The Company will also purchase 100% of CACH Acquisition, LLC and CAC Group Life, LLC, and 60.19% of CAC Holdings, LLC.
- Board Representation: The Seller Group will designate one Class III director and one observer to the Company's Board of Directors for up to six years or until they own less than 50% of the issued Equity Consideration.
- Restrictive Covenants: Key stakeholders of the Seller are expected to enter into non-compete, non-solicit, and confidentiality agreements.
Guidance, Risks, and Contingencies
Conditions to Closing: The transaction is subject to customary conditions, including the expiration of the Hart-Scott-Rodino Act waiting period, accuracy of representations and warranties, and performance of covenants.
Termination Rights: The agreement may be terminated if the transaction does not close by March 2, 2026, or if a governmental authority issues a final order prohibiting the transaction.
Risks and Forward-Looking Statements: The Company highlights risks regarding regulatory approvals, integration challenges, failure to achieve expected benefits, and general economic conditions. The filing includes a standard disclaimer that actual results may differ materially from forward-looking statements.
Investor Verification Checklist
- Verify the final purchase price adjustments and the exact number of shares issued at closing.
- Confirm the status of regulatory approvals, specifically the Hart-Scott-Rodino Act waiting period.
- Review the specific net commission and fee thresholds required to trigger the $250.0 million earnout.
- Monitor the integration progress and the appointment of the Seller-designated director and observer.
- Check for any updates regarding the March 2, 2026, termination deadline.